Zenotech Laboratories Limited (BOM:532039)

Market Cap	2.55B -20.5%
Revenue (ttm)	405.19M +4.6%
Net Income	-25.17M
EPS	-0.42
Shares Out	61.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,040
Open	41.71
Previous Close	41.80
Day's Range	41.55 - 43.20
52-Week Range	33.55 - 54.14
Beta	0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 23, 2026

About Zenotech Laboratories

Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1989
• Employees: 264
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532039

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 7, 2026

Data Sources Report a data error